Content about Dopamine reuptake inhibitors

January 4, 2012

The Food and Drug Administration has approved a generic version of a drug for attention deficit hyperactivity disorder made by Actavis, the drug maker said Wednesday.

October 17, 2011

Watson seeks approval for generic ADHD treatment

Generic drug maker Watson Pharmaceuticals is seeking Food and Drug Administration approval for a generic treatment for attention deficit hyperactivity disorder, the company said.

May 9, 2011

Impax confirms patent challenge for generic Concerta

Alza Corp. is attempting to block Impax Labs from developing a generic version of Alza's attention deficit hyperactivity disorder treatment.

February 1, 2011

FDA declines to approve Contrave

The Food and Drug Administration has turned down an application for an anti-obesity drug.

September 30, 2010

Mylan's generic Wellbutrin XL enters market

Mylan has launched a generic version of a common antidepressant, the company said Friday....

July 20, 2010

Caraco launches generic Wellbutrin SR

Generic drug maker Caraco Pharmaceutical Labs has launched a generic antidepressant, Caraco said Wednesday....